InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,606.00
(
-0.02%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.84
(
-0.77%
)
Bitcoin
63,127.11
(
-0.06%
)
Post# of 251747
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

GrthzGd

Send PM Follow Ignore
Followers 15
Posts 1610
Boards Moderated 1
Alias Born 09/07/2010

GrthzGd

Re: None

Monday, 06/26/2017 4:38:34 PM

Monday, June 26, 2017 4:38:34 PM

Post# of 251747
IPIX (formerly Cellceutix) up big today on breathless announcement it had consistently induced remission in its open label P2 trial of Brilacidin for mild-to-moderate Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two types of Inflammatory Bowel Disease (IBD), and would announce results July 13th. https://finance.yahoo.com/news/innovation-pharmaceuticals-completes-treatments-phase-133000345.html

“It is possible to be a normal decent person and yet to be fully alive.” - George Orwell

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up